RE:RE:RE:Kaly PotentialYou underevaluate the power of shorter on an penny stock, they can bring the price to the lowest with small amount...
Their's been naked shorting(illegal) of this stock for the last year and that's why the price is so low... on a penny stock that has no revenu the shorter will win on the short time over a year now....guess who have interest at keeping it low, and who can afford people to be there all the time to bash(big Pharma).
At this point we have no friend in the big pharma...
Phase 3 will come, but money will come way before phase 3 is done, the european market will use it this year.
Their no challenge to bring the CBD GVHD to market, it's being fast track and declare as an orphean drug, it doesn't get better then this for FDA approval process.
RE:RE:Kaly Potential
That's what worries me as well. By now, you would think the stock should have started to see a gradual appreciation in value to at least to the 0.07 to 0.10 range. I know that the future for KLY will be bright but the getting there may not be the Harlequin Romamce story that we're hoping for. IMO, the deal we are all waiting for may be complex in nature because the phase 3 trials still need to be completed, the harsh reality of the company's debt obligations, the amount of outstanding shares and the challenge of bringing a second CBD based drug to the market.